64 investors have funded 9 Life Sciences companies head-officed in Somerville, across 101 rounds (Mar 1994 – Jan 2026). They are ranked by how many Somerville companies in this market they have actually backed.
"In Somerville" describes the companies, not the investor: most of the money in any city comes from somewhere else, and the Where the money comes from section below shows exactly where it came from here.
Ranked by companies backed in this market and city, then by round count. "Led" counts rounds recorded with this investor as lead.
| # | Investor | Based in | Stages here | Companies | Rounds | Led | Latest | Portfolio total |
|---|---|---|---|---|---|---|---|---|
| 1 | Amgen | Thousand Oaks, United States | Series CSeries D | 2 | 3 | 2 | Sep 2023 | 53 |
| 2 | Y Combinator | Mountain View, United States | Seed | 2 | 2 | — | Sep 2021 | 5,648 |
| 3 | OMX Ventures | Lincolnshire, United States | Series DSeries A | 2 | 2 | 1 | Jun 2025 | 16 |
| 4 | Polaris Partners | Boston, United States | Series CSeries B | 1 | 3 | 2 | Mar 2022 | 330 |
| 5 | Flagship Pioneering | Cambridge, United States | Series BSeries ASeries C | 1 | 3 | 1 | Sep 2023 | 106 |
| 6 | Mitsui | Chiyoda City, Japan | Series BSeries C | 1 | 3 | — | May 2015 | 180 |
| 7 | Avenir Growth Capital | New York City, United States | Series BSeries CSeries D | 1 | 3 | 1 | Sep 2020 | 47 |
| 8 | Scientific Health Development | Dallas, United States | Series BSeries C | 1 | 3 | 1 | Mar 2022 | 14 |
| 9 | Cambia Health Solutions | Portland, United States | Series BSeries C | 1 | 3 | 2 | May 2015 | 17 |
| 10 | Willett Advisors | New York City, United States | Series BSeries CSeries D | 1 | 3 | 1 | Sep 2020 | 16 |
| 11 | Shumway Capital | Greenwich, United States | Series BSeries CSeries D | 1 | 3 | 1 | Sep 2020 | 13 |
| 12 | Norwich Ventures | Waltham, United States | Series BSeries A | 1 | 3 | 1 | Aug 2020 | 9 |
| 13 | Heritage Provider Network | Northridge, United States | Series BSeries C | 1 | 3 | — | May 2015 | 9 |
| 14 | Fidelity Investments | Boston, United States | Series BSeries C | 1 | 2 | — | Sep 2023 | 358 |
| 15 | Arch Venture Partners | Chicago, United States | Series BSeries C | 1 | 2 | — | Sep 2023 | 236 |
| 16 | T. Rowe Price | Baltimore, United States | Series BSeries C | 1 | 2 | — | Sep 2023 | 214 |
| 17 | Alexandria | Pasadena, United States | Series DSeries C | 1 | 2 | 1 | Apr 2019 | 231 |
| 18 | SIG | Bala Cynwyd, United States | Series CSeries D | 1 | 2 | — | Sep 2020 | 102 |
| 19 | Rock Health | San Francisco, United States | Series B | 1 | 2 | 1 | Aug 2020 | 90 |
| 20 | Celgene | Summit, United States | Series CSeries D | 1 | 2 | 1 | Apr 2019 | 53 |
| 21 | ADIA | Abu Dhabi, United Arab Emirates | Series BSeries C | 1 | 2 | — | Sep 2023 | 53 |
| 22 | OCV Partners | Los Angeles, United States | Series CSeries D | 1 | 2 | — | Sep 2020 | 14 |
| 23 | Symbiosis | Washington, DC, United States | Series CSeries D | 1 | 2 | — | Sep 2020 | 6 |
| 24 | TPTF | Taipei, Taiwan | Series CSeries D | 1 | 2 | — | Sep 2020 | 7 |
| 25 | Horizon Blue | Newark, United States | Series CSeries A | 1 | 2 | 2 | May 2016 | 7 |
| 26 | Morgan Noble | Washington, DC, United States | Series BSeries C | 1 | 2 | 1 | Jul 2019 | 4 |
| 27 | New Enterprise Associates | Menlo Park, United States | Post-IPO | 1 | 1 | — | Mar 1994 | 1,110 |
| 28 | Khosla Ventures | Menlo Park, United States | Series A | 1 | 1 | — | Jul 2014 | 680 |
| 29 | IDG Capital | New York City, United States | Series A | 1 | 1 | 1 | Jan 2026 | 636 |
| 30 | Floodgate | Menlo Park, United States | Series C | 1 | 1 | 1 | Nov 2016 | 195 |
| 31 | Walden International | San Francisco, United States | Series A | 1 | 1 | 1 | Jan 2026 | 175 |
| 32 | Jungle Ventures | Singapore, Singapore | Series A | 1 | 1 | — | Mar 2022 | 109 |
| 33 | March Capital | Santa Monica, United States | Series C | 1 | 1 | 1 | Sep 2023 | 76 |
| 34 | Morningside | Newton, United States | Series B | 1 | 1 | — | Nov 2021 | 101 |
| 35 | Bling Capital | San Francisco, United States | Series A | 1 | 1 | — | Nov 2020 | 81 |
| 36 | Version One Ventures | San Francisco, United States | Series C | 1 | 1 | 1 | Nov 2016 | 77 |
| 37 | Merck Global Health Innovation Fund | Kenilworth, United States | Series D | 1 | 1 | 1 | Jan 2020 | 61 |
| 38 | D1 Capital Partners | New York City, United States | Series C | 1 | 1 | 1 | Mar 2022 | 67 |
| 39 | Pillar VC | Boston, United States | Series A | 1 | 1 | — | Jun 2025 | 60 |
| 40 | NVentures | Santa Clara, United States | Series C | 1 | 1 | 1 | Sep 2023 | 63 |
| 41 | Echo Health Ventures | Seattle, United States | Series D | 1 | 1 | — | Apr 2019 | 32 |
| 42 | MSD Capital | New York City, United States | Series D | 1 | 1 | — | Sep 2020 | 44 |
| 43 | Second Avenue Partners | Seattle, United States | Series C | 1 | 1 | 1 | Nov 2016 | 30 |
| 44 | Altitude Life Science Ventures | Kirkland, United States | Series B | 1 | 1 | — | Nov 2021 | 24 |
| 45 | Cigna Ventures | Bloomfield, United States | Series D | 1 | 1 | 1 | Apr 2019 | 25 |
| 46 | Tarsadia | Newport Beach, United States | Series A | 1 | 1 | — | Jun 2025 | 25 |
| 47 | Intermountain Ventures | Salt Lake City, United States | Series A | 1 | 1 | — | Jun 2025 | 20 |
| 48 | Khosla Impact | Menlo Park, United States | Series A | 1 | 1 | — | Jul 2014 | 17 |
| 49 | The Baupost Group | Boston, United States | Series D | 1 | 1 | — | Sep 2020 | 20 |
| 50 | Humboldt Fund | New York City, United States | Series D | 1 | 1 | — | Sep 2020 | 17 |
| 51 | Pictet Group | Geneva, Switzerland | Series C | 1 | 1 | 1 | Sep 2023 | 19 |
| 52 | Germin8 Ventures | Chicago, United States | Series A | 1 | 1 | — | Jun 2025 | 12 |
| 53 | Alaska Permanent Fund | Juneau, United States | Series B | 1 | 1 | — | Nov 2021 | 9 |
| 54 | MSD Partners | New York City, United States | Series D | 1 | 1 | — | Sep 2020 | 13 |
| 55 | Lens Technology | Changsha, China | Series A | 1 | 1 | — | Jan 2026 | 6 |
| 56 | Mirae Asset Capital | Hong Kong, China | Series C | 1 | 1 | — | Sep 2023 | 3 |
| 57 | Hantan Capital | Xuhui, China | Seed | 1 | 1 | 1 | Dec 2016 | 4 |
| 58 | Lewis & Clark Partners | St. Louis, United States | Series A | 1 | 1 | 1 | Jun 2025 | 4 |
| 59 | Medtech Convergence Fund | Boston, United States | Series C | 1 | 1 | — | Mar 2022 | 3 |
| 60 | Samsung BioLogics | Incheon, South Korea | Series C | 1 | 1 | — | Dec 2024 | 3 |
| 61 | Octave Group | New York City, United States | Series D | 1 | 1 | — | Sep 2020 | 1 |
| 62 | OmniVision | Santa Clara, United States | Series A | 1 | 1 | — | Jan 2026 | 1 |
| 63 | Boston Angel Club | Waltham, United States | Seed | 1 | 1 | 1 | Dec 2016 | 1 |
| 64 | Wandai Capital | Somerville, United States | Seed | 1 | 1 | — | Dec 2016 | 1 |
Head office of the investors on this page.
Rounds by stage — where in a company's life this money arrives.
Total disclosed size of each round, not one investor's share.
How active this market has been.
Life Sciences companies head-officed in Somerville that took money from these investors.
| Company | Backers | Rounds | Disclosed | Latest round |
|---|---|---|---|---|
| Generate Biomedicines generatebiomedicines.com |
14 | 20 | $5.7B | Series C Dec 2024 |
| Finch Therapeutics finchtherapeutics.com |
14 | 25 | $1.7B | Series D Sep 2020 |
| Aitia aitiabio.com |
13 | 23 | $225.3M | Series D Jan 2020 |
| Matterworks matterworks.ai |
9 | 9 | $15.9M | Series A Jun 2025 |
| BrainCo brainco.tech |
7 | 7 | $1.2B | Series A Jan 2026 |
| Podimetrics podimetrics.com |
6 | 13 | $257.1M | Series C Mar 2022 |
| EyeNetra eyenetra.com |
2 | 2 | $8M | Series A Jul 2014 |
| Gynecare gynecare.com |
1 | 1 | $6M | Post-IPO Mar 1994 |
| Kiwi Biosciences kiwibiosciences.com |
1 | 1 | $125K | Seed Sep 2021 |
| Date | Investor | Company | Stage | Round size |
|---|---|---|---|---|
| Jan 2026 | Lens Technology | BrainCo | Series A | $286.3M |
| Jan 2026 | IDG CapitalLED | BrainCo | Series A | $286.3M |
| Jan 2026 | Walden InternationalLED | BrainCo | Series A | $286.3M |
| Jan 2026 | OmniVision | BrainCo | Series A | $286.3M |
| Jun 2025 | Tarsadia | Matterworks | Series A | — |
| Jun 2025 | Pillar VC | Matterworks | Series A | — |
| Jun 2025 | Germin8 Ventures | Matterworks | Series A | — |
| Jun 2025 | Intermountain Ventures | Matterworks | Series A | — |
| Jun 2025 | Lewis & Clark PartnersLED | Matterworks | Series A | — |
| Jun 2025 | OMX VenturesLED | Matterworks | Series A | — |
| Dec 2024 | Samsung BioLogics | Generate Biomedicines | Series C | — |
| Sep 2023 | Mirae Asset Capital | Generate Biomedicines | Series C | $273M |
| Sep 2023 | Pictet GroupLED | Generate Biomedicines | Series C | $273M |
| Sep 2023 | Fidelity Investments | Generate Biomedicines | Series C | $273M |
| Sep 2023 | T. Rowe Price | Generate Biomedicines | Series C | $273M |
| Sep 2023 | Arch Venture Partners | Generate Biomedicines | Series C | $273M |
| Sep 2023 | ADIA | Generate Biomedicines | Series C | $273M |
| Sep 2023 | AmgenLED | Generate Biomedicines | Series C | $273M |
| Sep 2023 | March CapitalLED | Generate Biomedicines | Series C | $273M |
| Sep 2023 | Flagship Pioneering | Generate Biomedicines | Series C | $273M |
Life Sciences investors in other cities
Other markets in Somerville